Sign Up to like & get
recommendations!
0
Published in 2019 at "European journal of medicinal chemistry"
DOI: 10.1016/j.ejmech.2019.01.004
Abstract: Inspired by the common structural characteristics of numerous known antitumor compounds targeting DNA or topoisomerase I, 3-(benzazol-2-yl)-quinoxaline-based scaffold was designed via the combination of two important privileged structure units -quinoxaline and benzazole. Thirty novel 3-(benzazol-2-yl)-quinoxaline…
read more here.
Keywords:
benzazol quinoxaline;
quinoxaline derivatives;
chemistry;
privileged structure ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "European journal of medicinal chemistry"
DOI: 10.1016/j.ejmech.2021.113632
Abstract: Privileged structures are conductive to discover novel bioactive substances because they can bind to multiple targets with high affinity. Quinones are considered to be a privileged structure and useful template for the design of new…
read more here.
Keywords:
advances quinones;
quinones privileged;
privileged structure;
recent advances ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Chemical reviews"
DOI: 10.1021/acs.chemrev.7b00020
Abstract: Privileged structures have been widely used as an effective template in medicinal chemistry for drug discovery. Chalcone is a common simple scaffold found in many naturally occurring compounds. Many chalcone derivatives have also been prepared…
read more here.
Keywords:
privileged structure;
medicinal chemistry;
chemistry;
chalcone privileged ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Scientific Reports"
DOI: 10.1038/s41598-019-46272-y
Abstract: Bisphenol A (BPA) is used as an industrial raw material for polycarbonate plastics and epoxy resins; however, various concerns have been reported regarding its status as an endocrine-disrupting chemical. BPA interacts not only with oestrogen…
read more here.
Keywords:
bisphenol;
privileged structure;
novel oestrogen;
discovery novel ... See more keywords